Keyphrases
Obese Men
100%
Glucagon-like
100%
Glucose-dependent Insulinotropic Polypeptide
100%
Randomized Crossover Study
100%
Energy Expenditure
100%
Energy Intake
100%
Glucose Infusion
53%
A1 Receptor
20%
Resting Energy Expenditure
13%
Eating Behavior
6%
Type 2 Diabetes Mellitus (T2DM)
6%
Rodents
6%
Glucagon
6%
Receptor Agonist
6%
Appetite Ratings
6%
Ad Libitum
6%
Weight Loss
6%
Placebo
6%
Mediating Effect
6%
Promoting Effect
6%
Sodium Chloride
6%
Receptor Activation
6%
Innovation Support
6%
No Significant Difference
6%
Saline Injection
6%
C-peptide
6%
Satiety
6%
Incretin Hormones
6%
Insulin
6%
OGTT
6%
AIMS™
6%
Crossover Design
6%
Denmark
6%
Agricultural and Biological Sciences
Energy Intake
100%
Cross-over Studies
100%
Gastric Inhibitory Polypeptide
100%
Glucagon-Like Peptide-1
100%
Glucagon-Like Peptide 1 Receptor
25%
Agonist
16%
Endpoints
16%
Placebo
8%
Gastric Inhibitory Polypeptide Receptor
8%
Incretin
8%
Scanning Electron Microscopy
8%
C-Peptide
8%
Glucagon
8%
Satiety
8%
Table Salt
8%
Neuroscience
Gastric Inhibitory Polypeptide
100%
Crossover Study
100%
Energy Expenditure
100%
Glucagon-Like Peptide-1
100%
Resting Energy Expenditure
16%
Glucagon-Like Peptide 1 Receptor
16%
Incretin
8%
Sodium Chloride
8%
Satiety
8%
Scanning Electron Microscopy
8%
Receptor Agonists
8%
Eating Behavior
8%
Glucagon
8%
C Peptide
8%
Placebo
8%
Glucagon-Like Peptide-1 Agonist
8%
Gastric Inhibitory Polypeptide Receptor
8%
Biochemistry, Genetics and Molecular Biology
Energy Expenditure
100%
Gastric Inhibitory Polypeptide
100%
Glucagon-Like Peptide-1
100%
Glucagon-Like Peptide 1 Receptor
25%
Receptor Agonists
16%
Resting Energy Expenditure
16%
Gastric Inhibitory Polypeptide Receptor
8%
C-Peptide
8%
Glucagon
8%
Incretin
8%
Scanning Electron Microscopy
8%
Satiety
8%
Pharmacology, Toxicology and Pharmaceutical Science
Gastric Inhibitory Polypeptide
100%
Glucagon-Like Peptide-1
100%
Obesity
100%
Glucagon-Like Peptide 1 Receptor
16%
Scanning Electron Microscopy
8%
Placebo
8%
Table Salt
8%
Receptor Agonist
8%
Glucagon Like Peptide 1 Receptor Agonist
8%
Glucagon
8%
Incretin
8%
Non Insulin Dependent Diabetes Mellitus
8%
C Peptide
8%
Gastric Inhibitory Polypeptide Receptor
8%
Food Science
Energy Intake
100%
Glucagon-Like Peptide-1
100%
Glucagon
6%
Eating Behavior
6%
Table Salt
6%
Scanning Electron Microscopy
6%
Insulin
6%
Incretin
6%